Myohub MD Tablet combines Myo-Inositol 1.1gm, D-Chiro Inositol 27.6mg, L-Methyl Folate 1mg, and Vitamin D3 1000IU, offering a comprehensive nutraceutical formulation for women’s reproductive and metabolic health. The combination supports hormonal balance, ovarian function, and insulin sensitivity, making it ideal for managing PCOS, infertility, and metabolic disorders.
Myo-Inositol plays a key role in improving ovarian function and regulating menstrual cycles, while D-Chiro Inositol helps enhance insulin sensitivity and ovulation. L-Methyl Folate contributes to proper folate levels for reproductive health, and Vitamin D3 supports bone metabolism and overall endocrine function.
This tablet is widely used in the gynecology and fertility segment and is in high demand among gynecologists, endocrinologists, IVF clinics, and specialty centers. Its combination formulation ensures convenience for patients while improving clinical outcomes, increasing prescription repeatability.
For PCD pharma franchise and B2B partners, Myohub MD Tablet offers a profitable and high-demand opportunity. Its clinically backed formulation, broad-spectrum fertility support, and growing awareness in women’s health make it a strategic product for domestic and export markets, ensuring strong business growth and attractive margins.